dmard

Actarit (4-acetylaminophenylacetic acid) 是一种口服具有活性的化合物，可用于抗风湿研究以及 II 型胶原诱导性关节炎的研究。

CR6086 is a novel, potent EP4 antagonist showing favourable immunomodulatory properties, striking DMARD effects in rodents, and anti-inflammatory activity targeted to immune-mediated inflammatory diseases and distinct from the general effects of cyclooxygenase inhibitors. CR6086 showed selectivity and high affinity for the human EP4 receptor (Ki = 16.6 nM) and functioned as a pure antagonist (half-maximal inhibitory concentration, 22 nM) on PGE2-stimulated cAMP production.

Indomethacin farnesil (Infree) 是具有口服活性的 Indomethacin 前药，可通过干扰溶酶体的正常功能来破坏自噬流，有抗炎和抗风湿作用。它是一种可透过血脑屏障的，非选择性的 COX1和 COX2抑制剂，在 CHO 细胞中，对人 COX-1 和 COX-2 的IC50值分别为 18 nM 和 26 nM。